News Item

  • June 16, 2020

–Multiple oncology-focused programs poised to enter clinical trials in 2021 and 2022– WATERTOWN, Mass, June 16, 2020 – C4 Therapeutics,...

News Item

  • September 23, 2019

WATERTOWN, Mass. – C4 Therapeutics (C4T) today announced the appointment of Ryan B. Corcoran, M.D., Ph.D., to the Company’s Scientific Advisory Board...

News Item

  • March 13, 2019

WATERTOWN, Mass. – March 13, 2019 – C4 Therapeutics (C4T) today announced the appointment of Adam Crystal M.D., Ph.D. as...

News Item

  • January 4, 2019

C4 Therapeutics Announces Transformation of Strategic Collaboration to Discover and Develop Degrader-based Medicines with Roche WATERTOWN, Mass. – C4 Therapeutics...

News Item

  • January 4, 2019

Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions C4T’s targeted...